QLS1304
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for QLS1304, covering 2026-01-12 to 2026-01-12. Get the full timeline:
Most recent: Clinical Trial Update: Phase Ib/II Clinical Study of QLS1304 Combined With Endocrine Therapy in the Treatment of ER+/HER2- Breast Cancer Patients [Phase 1, Phase 2]